The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Potential Additional Tier 1 Transaction

8 Jun 2015 10:45

RNS Number : 4967P
Bank of Ireland(Governor&Co)
08 June 2015
 



The Governor and Company of the Bank of Ireland (the ''Group'')

Potential Additional Tier 1 Transaction

8 June 2015

_______________________________________________________________________________

 

The Governor and Company of the Bank of Ireland ("the Bank") has mandated Deutsche Bank and UBS Investment Bank as Joint Structuring Advisors and Joint Bookrunners and Bank of America Merrill Lynch, Credit Suisse, Davy and Morgan Stanley as Joint Bookrunners for the issue of EUR-denominated RegS CRR compliant 5.125% CET1 trigger Fixed Rate Reset Additional Tier 1 Perpetual Contingent Temporary Write-Down Securities (the "Securities"). The issue and sale of the Securities remains subject to market conditions and will follow a UK and European roadshow which will commence on 9 June 2015. FCA/ICMA stabilisation.

Ends

 

For further information please contact:

 

Bank of Ireland

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Brian Kealy Head of Capital Management +353 (0)766 23 4719

Colin Reddy Deputy Head of Capital Management +353 (0)766 23 4722

Mark Spain Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

  

Forward Looking Statement

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the 'Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal', 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, level of ownership by the Irish Government, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, future payment of dividends, the implementation of changes in respect of certain of the Group's pension schemes, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following: geopolitical risks, such as those associated with crises in the Middle East and increasing political tensions in respect of the Ukraine, which could potentially adversely impact the markets in which the Group operates; concerns on sovereign debt and financial uncertainties in the EU and in member countries such as Greece and the potential effects of those uncertainties on the Group; general and sector specific economic conditions in Ireland, the United Kingdom and the other markets in which the Group operates; the ability of the Group to generate additional liquidity and capital as required; the effects of extensive asset quality review and stress tests conducted by the European Central Bank any capital or other assessments undertaken by regulators; property market conditions in Ireland and the United Kingdom; the potential exposure of the Group to various types of market risks, such as interest rate risk, foreign exchange rate risk, credit risk and commodity price risk; deterioration in the credit quality of the Group's borrowers and counterparties, as well as increased difficulties in relation to the recoverability of loans and other amounts due from such borrowers and counterparties, have resulted in significant increases, and could result in further significant increases in the Group's impaired loans and impairment provisions; the impact on lending and other activity arising from emerging macro prudential policies; the performance and volatility of international capital markets; the effects of the Irish Government's stockholding in the Group (through the Ireland Strategic Investment Fund) and possible changes in the level of such stockholding; the impact of downgrades in the Group's or the Irish Government's credit ratings or outlook; the stability of the eurozone; changes in the Irish and United Kingdom banking systems; changes in applicable laws, regulations and taxes in jurisdictions in which the Group operates particularly banking regulation by the Irish and United Kingdom Governments together with the operation of the Single Supervisory Mechanism and the establishment of the Single Resolution Mechanism the exercise by regulators of powers of regulation and oversight in Ireland and the United Kingdom; the introduction of new government policies or the amendment of existing policies in Ireland or the United Kingdom; the outcome of any legal claims brought against the Group by third parties or legal or regulatory proceedings or any Irish banking inquiry more generally, that may have implications for the Group; the development and implementation of the Group's strategy, including the Group's ability to achieve net interest margin increases and cost targets; the Group's ability to address weaknesses or failures in its internal processes and procedures including information technology issues and equipment failures and other operational risks; the responsibility of the Group for contributing to compensation schemes in respect of banks and other authorised financial services firms in Ireland and the United Kingdom who may be unable to meet their obligations to customers; the inherent risk within the Group's life assurance business involving claims, as well as market conditions generally; potential further contributions to the Group sponsored pension schemes if the value of pension fund assets is not sufficient to cover potential obligations and the impact of the continuing implementation of significant regulatory developments such as Basel III, Capital Requirements Directive (CRD) IV, Solvency II and the Recovery and Resolution Directive.

 

Nothing in this document should be considered to be a forecast of future profitability or financial position and none of the information in this document is or is intended to be a profit forecast or profit estimate. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANKPELASEEF
Date   Source Headline
7th Jul 20174:30 pmRNSNotification of Change in Director's Details
29th Jun 20174:30 pmRNSUpdate on corporate reorganisation of the Group
23rd Jun 20171:30 pmRNSHigh Court approval of the Scheme
8th Jun 20174:00 pmRNSNotification of Significant shareholding
6th Jun 20174:00 pmRNSNotification of Significant shareholding
2nd Jun 20173:00 pmRNSNotification of Significant shareholding
30th May 20175:00 pmRNSNotification of Significant shareholding
26th May 201712:00 pmRNSChange of Group External Auditor for 2018
19th May 20175:00 pmRNSNotification of Significant Shareholding
17th May 20175:15 pmRNSAppointment of new Group CEO
15th May 20172:00 pmRNSUpdate on the resolution strategy for the Group
11th May 20175:00 pmRNSNotification of Significant shareholding
10th May 20175:00 pmRNSNotification of Significant shareholding
5th May 20175:00 pmRNSNotification of Significant shareholding
5th May 20174:00 pmRNSNotification of Significant Shareholding
4th May 20172:00 pmRNSNotification of Major Holdings
3rd May 20177:00 amRNSMain Securities Market Notice
28th Apr 20176:07 pmRNSAVONDALE SECURITIES S.A.
28th Apr 20175:47 pmRNSNotice of Results of Court Meeting and EGC
28th Apr 20175:44 pmRNSNotification of Significant Shareholding
28th Apr 20175:40 pmRNSResults of the Annual General Court
28th Apr 20177:00 amRNSQ1 2017 Interim Management Statement
21st Apr 20174:00 pmRNSAppointment of joint corporate broker
18th Apr 20172:00 pmRNSNotification of Significant Shareholding
7th Apr 20175:00 pmRNSMajor Interest in Shares Notification
4th Apr 20172:02 pmRNSTotal Voting Rights
4th Apr 20172:00 pmRNSUpdate on the resolution strategy for the Group
31st Mar 201712:45 pmRNSBOI UK Holdings plc - Redemption of sub-debt
31st Mar 201712:01 pmRNSUpdate on the resolution strategy for the Group
24th Mar 20172:00 pmRNSCEO intention to step down before the end of 2017
15th Mar 20172:03 pmRNSTotal Voting Rights
15th Mar 20172:02 pmRNSNotice of Annual General Court
8th Mar 20175:01 pmRNSDirectorate Change
3rd Mar 201712:00 pmRNSNotification of Significant Shareholding
24th Feb 20175:00 pmRNSBank of Ireland Mortgage Bank
24th Feb 20177:04 amRNSPillar 3 Disclosures for 31 December 2016
24th Feb 20177:00 amRNSPublishes Annual Results
3rd Feb 20177:00 amRNSUpdate on the Resolution Strategy for the Group
13th Jan 20179:20 amRNSChange in Director's Details
23rd Dec 20168:00 amRNSBOI Capital Developments
1st Dec 20167:00 amRNS2016 Supervisory Review and Evaluation Process
28th Oct 20167:00 amRNSInterim Management Statement - Q3 2016 update
25th Oct 20165:01 pmRNSNotification of Significant Shareholding
20th Oct 20162:36 pmRNSNotification of Significant Shareholding
12th Oct 20165:14 pmRNSNotification of Significant Shareholding
28th Sep 20165:00 pmRNSNotification of Significant Shareholding
2nd Aug 20164:30 pmRNSDirector/PDMR Shareholding
2nd Aug 20164:19 pmRNSNotification of Significant Shareholding
1st Aug 20167:00 amRNSEBA Stress Test 2016
29th Jul 20167:00 amRNSInterim Results 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.